Find information on thousands of medical conditions and prescription drugs.

Atrioventricular septal defect

Atrioventricular septal defect (AVSD), previously known as "common atrioventricular canal" (CAVC) or "endocardial cushion defect", is characterized by a deficiency of the atrioventricular septum of the heart. It is caused by an abnormal or inadequate fusion of the superior and inferior endocardial cushions with the mid portion of the atrial septum and the muscular portion of the ventricular septum. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

If there is a defect in this septum, it is possible for blood to travel from the left side of the heart to the right side of the heart, or the other way around. Since the right side of the heart contains venous blood with a low oxygen content, and the left side of the heart contains arterial blood with a high oxygen content, it is beneficial to prevent any communication between the two sides of the heart and prevent the blood from the two sides of the heart from mixing with each other.

This type of congenital heart defect is associated with patients with Down syndrome (trisomy 21) or heterotaxy syndromes. 70-80% of patients undergoing surgery for AVSD have trisomy 21.

Diagnosis

VSDs can be detected by cardiac auscultation, they cause atypical murmurs and loud heart tones. Confirmation of findings from cardiac auscultation can be obtained with a cardiac ultrasound (echocardiography) (less invasive) and cardiac catheterization (more invasive).

Treatment

Treatment is surgical. Open surgical procedures require a heart-lung machine and are done with a median sternotomy. Percutaneous endovascular procedures are less invasive and can be done on a beating heart, but are only suitable for certain patients.

Litterature

  • Shinebourne EA and Yen Ho S: Atrioventricular Septal Defect: Complete and Partial. Chapter 21 in Gatzoulis MA, Webb GD and Daubeney PEF: Diagnosis and Management of Adult Congenital Heart Disease. Edinburgh, 2003.

Read more at Wikipedia.org


[List your site here Free!]


Transcatheter closure of traumatic ventricular septal defect : an alternative to surgery - selected report
From CHEST, 6/1/03 by David Pesenti-Rossi

The incidence of ventricular septal defect (VSD) occurs in up to 4.5% of penetrating cardiac trauma. We report a patient with persistent VSD who underwent surgical repair with significant left-to-right shunt and signs of heart failure. We performed a successful transcatheter closure of the VSD with an Amplatzer septal occluder (AGA Medical Corporation; Golden Valley, MN).

Key words: posttraumatic ventricular septal defect; transcatheter closure

Abbreviation: VSD = ventricular septal defect

**********

Review of the literature of penetrating cardiac trauma reports the incidence of ventricular septal defect (VSD) to be 4.5%. Most of patients are usually operated on because of heart failure and/or significant left-to-right shunt. We report a case report of a patient with penetrating chest trauma corrected by surgery, who subsequently developed heart failure due to a large persistent VSD. Successful transcatheter closure of the VSD was then performed with an Amplatzer septal occluder (AGA Medical Corporation; Golden Valley, MN).

CASE REPORT

A 40-year-old man, with no medical history, was stabbed with a knife in the anterior chest. He was hospitalized in a severe state of shock. After resuscitation, he was taken to the operating room. An emergency thoracotomy was done to relieve cardiac tamponade and to suture a right ventricular wound. Postoperatively, echocardiography revealed a large muscular VSD and significant tricuspid regurgitation due to a prolapsed septal valve. He was reoperated on the next day to close the VSD with a Teflon patch and repair two papillary muscles of the tricuspid valve because of significant regurgitation.

The postoperative course was uneventful. One month later, he presented short of breath with signs of heart failure. Echocardiography showed a large residual VSD with significant left-to-right shunting secondary to a dehiscence of the patch and tricuspid insufficiency grade 4/4. It was then planned to close the defect transvenously.

A cardiac catheterization was performed, and pressure records were as follows: left ventricle, 102/0 mm Hg; right ventricle, 35/0 mm Hg; pulmonary artery, 30/16/23 mm Hg; and fight atrium, 30/5/19 mm Hg. The left-to-right shunt was 3.7/1 by oximetry. A left ventricular angiography showed a 12-mm muscular VSD (Fig 1). We decided to close the defect with a 12-mm Amplatzer muscular VSD occluder. This device is made from Nitinol (1) wire mesh that has been shaped by heat treatment into a central stent with two retention discs. It is very similar to the atrial septal defect device. To place a 9F-delivery sheath within the left ventricle, an arteriovenous loop was first introduced from the arterial side with capture of 0.020-inch guidewire in the pulmonary artery. During placement of the occluder across the defect, the device slipped into the fight ventricle and was then retrieved within the delivery sheath. We decided thus to use a 15-mm Amplatzer septal occluder, which was similarly delivered (Fig 2). After release, control left ventricular angiography showed good position of the device and minimal residual shunt. On the next day, he presented with pallor and significant hematuria. Blood tests revealed intravascular hemolysis; his hemoglobin level fell from 14 to 8.5 g/dL, and haptoglobin level was 0.08 g/L. He did not require any blood transfusion, and hemolysis stopped spontaneously after a few days. Six months later, repeat echocardiography showed a tiny residual shunt and persistent tricuspid insufficiency. This patient is waiting for further surgery to repair the tricuspid valve.

DISCUSSION

According to literature, VSDs associated with cardiac trauma, either penetrating or blunt, (2) are uncommon but not rare. The mechanisms of VSD from blunt cardiac injury are believed to be either the acute compression of the heart between the sternum and the spine or rapid deceleration. VSD may here result from traumatic myocardial infarction due to an intimal tear of the coronary artery with thrombosis, spasm, embolism, dissection, or myocardial contusion. (3,4)

Cardiac injury following blunt trauma (3) is often unsuspected but may also produce instantaneous congestive heart failure due myocardial injury, VSD, and valvular injury. In most of the cases, VSD occurs in the muscular portion of the septum.

According to the literature, the decision to perform surgical repair is made on the amount of left-to-right shunt and presence of heart failure. (2,4) Transcatheter closure of a posttraumatic VSD can be an alternative to surgery in symptomatic patients with a systemic-to-pulmonary ratio > 1.5 following a blunt chest trauma or persistent shunt after surgical repair; however, a conservative approach has been recommended for small traumatic VSD with a pulmonary-to-systemic ratio < 2:1 because these defects may be well tolerated and close over time. More recently, some have reported transcatheter closure for perimembranous or muscular VSD using a new device, the Amplatzer VSD occluder. (1,5-8) In such cases, the VSD must not be too close to the aortic and atrioventricular valves to allow a safe procedure and no valvular device protrusion. No episode of hemolysis has been yet reported. We do think, according to the past experience in transcatheter patent ductus arteriosus closure, that hemolysis is related to high velocity jet through and around the occluder leading to destruction of RBCs. Usually, this resolved after complete closure of the defect by placement of a second occluder or simply after endothelialization of the device as was probably observed in our patient. To conclude, transcatheter closure appears to be a good option for patients beyond infancy with a posttraumatic muscular VSD that is hemodynamically significant.

REFERENCES

(1) Tofeig M, Patel RG, Walsh KP. Transcatheter closure of a mid-muscular ventricular septal defect with an Amplatzer VSD occluder device. Heart 1999; 81:438-440

(2) Olsovsky MR, Jopaz O, DiSciascio G, et al. Acute traumatic septal rupture. Am Heart J 1996; 131:1039-1041

(3) Engelman RM, Rousou JA, Schweiger M. Traumatic ventricular septal defect following closed-chest massage: a new approach to closure. Ann Thorac Surg 1984; 38:529-531

(4) Genoni M, Jenni R, Turina M. Traumatic ventricular septal defect. Heart 1997; 78:316-318

(5) Thanopoulos BD, Tsaousis GS, Konstadopoulo GN, et al. Transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol 1999; 33:1935-1939

(6) Hijazi ZM, Hakim F, Al-Fadley F, et al. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv 2000; 49:167-172

(7) Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv 2002; 56:508-515

(8) Chessa M, Carminati M, Cao QL, et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 2002; 14:322-327

* From the Departments of Pediatric Cardiology (Drs. Pesenti-Rossi, Godart, and Rey) and Cardiac and Vascular Surgery (Dr. Dubar), Cardiac Hospital, University of Lille, Lille, France.

Manuscript received July 11, 2002; revision accepted October 10, 2002.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (e-mail: permissions@chestnet.org).

Correspondence to: Francois Godart, MD PhD Service des Maladies Cardiovasculaires Infantiles et Congenitales Hopital Cardiologique, Bvd du Pr J. Leclercq, 59037, Lille cedex, France; e-mail: f-godart@chru-lille.fr

COPYRIGHT 2003 American College of Chest Physicians
COPYRIGHT 2003 Gale Group

Return to Atrioventricular septal defect
Home Contact Resources Exchange Links ebay